Using confocal laser endomicroscopy to diagnose pancreatic cysts
Official title: Confocal Laser Endomicroscopy as an IMaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Run by Ohio State University Comprehensive Cancer Center · NCT03492151 · Data updated 2026-11-12
This study is testing a new imaging technique to see if it can help doctors better diagnose pancreatic cysts in patients who are already being checked for these issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Locations | 10 sites (Scottsdale, Arizona and 9 other locations) |
| Status | Recruiting |
| Started | October 1, 2018 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT03492151 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are referred for EUS-FNA of pancreatic cysts that are 2.0 cm or larger and for whom surgery is being considered.
✕Probably not a fit
Patients who are unable to provide informed consent, have prior pancreatic cancer, or have conditions that prevent them from tolerating the procedure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of confocal laser endomicroscopy (nCLE) as an imaging biomarker for diagnosing pancreatic cystic lesions (PCL). Patients referred for endoscopic ultrasound (EUS) evaluation of PCL will undergo nCLE imaging, followed by EUS-guided fine needle aspiration (FNA) for cyst fluid analysis. The results from the cyst fluid, including cytology and molecular analysis, will be compared against surgical histopathology to determine the accuracy of the imaging technique. The study seeks to improve diagnostic accuracy and guide treatment decisions for patients with pancreatic cysts.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate diagnoses of pancreatic cysts, potentially improving patient outcomes and treatment strategies.
How similar studies have gone: While the use of confocal laser endomicroscopy in this context is relatively novel, similar imaging techniques have shown promise in other studies for improving diagnostic accuracy in various conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient age 18 years or older * All patients referred for EUS-FNA of accessible PCL where surgery is contemplated * Minimum cyst size should be ≥ 2.0 cm as determined by prior cross-sectional imaging studies Exclusion Criteria: * Unable to obtain informed consent * Unable to tolerate the procedure * Women with known pregnancy at time of procedure * Patient age less than 18 years * Bleeding diathesis * Known allergy to fluorescein * Prior pancreatic cancer * Prior pancreatic surgery
Where it's running
-
Mayo Clinic Scottsdale Campus
Scottsdale, Arizona, United States Recruiting -
Stanford Hospital
Stanford, California, United States Recruiting -
Yale School of Medicine
New Haven, Connecticut, United States Recruiting -
The Johns Hopkins Hospital
Baltimore, Maryland, United States Recruiting -
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting -
NYU Langone Health
Garden City, New York, United States Recruiting
Show 4 more locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, United States Recruiting -
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States Recruiting -
Baylor College of Medicine
Houston, Texas, United States Recruiting -
Parkview Hospital Randallia
Fort Wayne, Indiana, United States Active not recruiting
Study contacts
- Principal investigator: Somashekar Krishna, MD, MPH — Ohio State University
- Study coordinator: Megan Fry
- Email: Megan.Fry@osumc.edu
- Phone: 614-293-1056
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood and cyst fluid analysis from patients undergoing pancreatic cyst surgery
Researchers will collect blood and cyst fluid from adults having pancreatic cysts surgically removed to test for DNA, RNA, and proteins.
-
In-depth characterisation of biliary strictures and hepato‑pancreato‑biliary focal lesions to support new diagnostic technologies
This project will collect detailed imaging and tissue data from adults with suspected bile duct, liver, pancreatic, or gallbladder lesions to help develop and test better diagnostic tools.
-
Patient-reported outcomes after pancreatic surgery
This project will see how pancreatic surgery affects quality of life and whether adults who have pancreatic resection feel satisfied with their decision over time.
-
Laparoscopic versus robot-assisted left-sided pancreas removal for benign and premalignant lesions
This trial will randomize adults needing elective left-sided pancreas removal for benign or premalignant lesions to laparoscopic or robot-assisted minimally invasive surgery to see if one approach leads to faster recovery and fewer complications.
-
Examining the link between pancreatic steatosis and pancreatic cysts and cancer
This study is trying to see if having fat in the pancreas is more common in people with pancreatic cysts that could turn into cancer and those with pancreatic cancer.
-
Using artificial intelligence to improve endoscopic ultrasound for pancreatic diseases
This study is testing whether an artificial intelligence system can help doctors find problems in the pancreas during ultrasound exams to improve diagnosis and reduce mistakes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.